Adiponectin levels in patients with colorectal cancer and adenoma: A meta-analysis

European Journal of Cancer Prevention

Volumn 21, Issue 2, 2012, Pages 126-133

  An, Wei ^a   Bai, Yu ^a   Deng, Shang Xin ^a   Gao, Jie ^a   Ben, Qi Wen ^a   Cai, Quan Cai ^a   Zhang, Hua Gao ^a   Li, Zhao Shen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adiponectin; Colorectal adenoma; Colorectal cancer; Meta analysis

Indexed keywords

ADIPONECTIN;

ARTICLE; CASE CONTROL STUDY; COLORECTAL ADENOMA; COLORECTAL CANCER; DISEASE ASSOCIATION; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN POLYMORPHISM; SAMPLE SIZE; SENSITIVITY ANALYSIS;

ADENOMA; ADIPONECTIN; ALGORITHMS; BLOOD CHEMICAL ANALYSIS; CARCINOMA; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; HUMANS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84858291325     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32834c9b55     Document Type: Article

References (47)

1. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101.
2. Bergstrom A, Pisani P, Tenet V, Wolk A, Adami HO (2001). Overweight as an avoidable cause of cancer in Europe. Int J Cancer 91:421-430. (Pubitemid 32049639)
3. Bianchini F, Kaaks R, Vainio H (2002). Overweight, obesity, and cancer risk. Lancet Oncol 3:565-574. (Pubitemid 34993644)
4. Carvajal-Carmona LG, Spain S, Kerr D, Houlston R, Cazier JB, Tomlinson I (2009). Common variation at the adiponectin locus is not associated with colorectal cancer risk in the UK. Hum Mol Genet 18:1889-1892.
5. Catalan V, Gomez-Ambrosi J, Rodriguez A, Ramírez B, Silva C, Rotellar F, et al. (2011). Up-regulation of the novel proinflammatory adipokines lipocalin-2, chitinase-3 like-1 and osteopontin as well as angiogenic-related factors in visceral adipose tissue of patients with colon cancer. J NutrBiochem22:634-641.
6. Dai Z, Xu YC, Niu L (2007). Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol 13:4199-4206. (Pubitemid 47377159)
7. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials 7:177-188. (Pubitemid 17189972)
8. Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634. (Pubitemid 27387172)
9. Erarslan E, Turkay C, Koktener A, Koca C, Uz B, Bavbek N (2009). Association of visceral fat accumulation and adiponectin levels with colorectal neoplasia. Dig Dis Sci 54:862-868.
10. Fenton JI, Birmingham JM, Hursting SD, Hord NG (2008). Adiponectin blocks multiple signaling cascades associated with leptin-induced cell proliferation in Apc Min/+ colon epithelial cells. Int J Cancer 122:2437-2445. (Pubitemid 351590475)
11. Fujisawa T, Endo H, Tomimoto A, Sugiyama M, Takahashi H, Saito S, et al. (2008). Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut 57:1531-1538.
12. Fukumoto J, Otake T, Tajima O, Tabata S, Abe H, Mizoue T, et al. (2008). Adiponectin and colorectal adenomas: Self Defense Forces Health Study. Cancer Sci 99:781-786. (Pubitemid 351448083)
13. Giovannucci E (1995). Insulin and colon cancer. Cancer Causes Control 6:164-179.
14. Gonullu G, Kahraman H, Bedir A, Bektas A, Yucel I (2010). Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int J Colorectal Dis 25:205-212.
15. Guadagni F, Roselli M, Martini F, Spila A, Riondino S, D'Alessandro R, et al. (2009). Prognostic significance of serum adipokine levels in colorectal cancer patients. Anticancer Res 29:3321-3327.
16. Hanley AJ, Bowden D,Wagenknecht LE, Balasubramanyam A, Langfeld C, Saad MF, et al. (2007). Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans. J Clin Endocrinol Metab 92:2665-2671. (Pubitemid 47037374)
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ 327:557-560. (Pubitemid 37088507)
18. Hivert MF, Sun Q, Shrader P, Mantzoros CS, Meigs JB, Hu FB (2011). Higher adiponectin levels predict greater weight gain in healthy women in the Nurses' Health Study. Obesity (Silver Spring) 19:409-415.
19. Hozo SP, Djulbegovic B, Hozo I (2005). Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13.
20. Jee SH, Kim HJ, Lee J (2005). Obesity, insulin resistance and cancer risk. Yonsei Med J 46:449-455. (Pubitemid 41283053)
21. Jonathan AC, Sterne ME, Smith GD (2001). Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. Br Med J 323:101-105.
22. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K (2006). Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116:1784-1792. (Pubitemid 44033298)
23. Kaklamani VG, Wisinski KB, Sadim M, Gulden C, Do A, Offit K, et al. (2008). Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA 300:1523-1531.
24. Kemik O, Sumer A, Kemik AS, Hasirci I, Purisa S, Dulger AC, et al. (2010). The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer. World J Surg Oncol 8:85.
25. Komninou D, Ayonote A, Richie JP Jr., Rigas B (2003). Insulin resistance and its contribution to colon carcinogenesis. Exp Biol Med (Maywood) 228:396-405. (Pubitemid 37203647)
26. Kumor A, Daniel P, Pietruczuk M, Malecka-Panas E (2009). Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis 24:275-281.
27. Larsson SC, Wolk A (2007). Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 86:556-565. (Pubitemid 47435820)
28. Larsson SC, Orsini N, Wolk A (2005). Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97:1679-1687. (Pubitemid 41672234)
29. Li S, Shin HJ, Ding EL, van Dam RM (2009). Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302:179-188.
30. Liu T, Li G, Li L, Korantzopoulos P (2007). Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 49:1642-1648. (Pubitemid 46551628)
31. Lukanova A, Soderberg S, Kaaks R, Jellum E, Stattin P (2006). Serum adiponectin is not associated with risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 15:401-402. (Pubitemid 43342195)
32. Mutoh M, Teraoka N, Takasu S, Takahashi M, Onuma K, Yamamoto M, et al. (2011). Loss of adiponectin promotes intestinal carcinogenesis in min and wild-type mice. Gastroenterology 140:2000 e2-2008 e2.
33. Nakajima TE, Yamada Y, Hamano T, Matsuda T, Fujita S, Kato K, et al. (2010). Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci 101:1286-1291.
34. Nakashima R, Kamei N, Yamane K, Nakanishi S, Nakashima A, Kohno N (2006). Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrinol Metab 91:3873-3877. (Pubitemid 44536857)
35. Nayak BS, Ramsingh D, Gooding S, Legall G, Bissram S, Mohammed A, et al. (2010). Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians. Prim Care Diabetes 4:187-192.
36. Nishida M, Funahashi T, Shimomura I (2007). Pathophysiological significance of adiponectin. Med Mol Morphol 40:55-67. (Pubitemid 47305235)
37. Nishihara T, Baba M, Matsuda M, Inoue M, Nishizawa Y, Fukuhara A, et al. (2008). Adiponectin deficiency enhances colorectal carcinogenesis and liver tumor formation induced by azoxymethane in mice. World J Gastroenterol 14:6473-6480.
38. Osório-Costa F, Rocha ZG, Dias MM, Carvalheira CJ (2009). Epidemiological and molecular mechanisms aspects linking obesity and cancer. Arq Bras Endocrinol Metab 53:213-226.
39. Otake S, Takeda H, Suzuki Y, Fukui T, Watanabe S, Ishihama K, et al. (2005). Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res 11:3642-3646. (Pubitemid 40685579)
40. Otake S, Takeda H, Fujishima S, Fukui T, Orii T, Sato T, et al. (2010). Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer. World J Gastroenterol 16:1252-1257.
41. Pechlivanis S, Bermejo JL, Pardini B, Naccarati A, Vodickova L, Novotny J, et al. (2009). Genetic variation in adipokine genes and risk of colorectal cancer. Eur J Endocrinol 160:933-940.
42. Pisani P (2008). Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem 114:63-70.
43. Stocks T, Lukanova A, Johansson M, Rinaldi S, Palmqvist R, Hallmans G, et al. (2008). Components of the metabolic syndrome and colorectal cancer risk: a prospective study. Int J Obes (Lond) 32:304-314. (Pubitemid 351271779)
44. Sugiyama M, Takahashi H, Hosono K, Endo H, Kato S, Yoneda K, et al. (2009). Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int J Oncol 34:339-344.
45. Trujillo ME, Scherer PE (2005). Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257:167-175. (Pubitemid 40193966)
46. Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS (2005). Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 97:1688-1694. (Pubitemid 41672235)
47. Yamaji T, Iwasaki M, Sasazuki S, Tsugane S (2010). Interaction between adiponectin and leptin influences the risk of colorectal adenoma. Cancer Res 70:5430-5437.